Strategic Wealth Partners, Ltd.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1720777
INDEPENDENCE, OH
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,424
-$7,753 QoQ
Shares Held
52
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,151
of 1,322 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Strategic Wealth Partners, Ltd. holds $2,710,636 across 28 Biotechnology names. REGN ranks #4 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,784 | $2,376,356 | |
| 2 | ARGX |
Argenx SE
|
72 | $66,799 | |
| 3 | CMPX |
Compass Therapeutics, Inc.
|
28,575 | $62,579 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
52 | $32,424 | |
| 5 | TECH |
BIO-TECHNE Corp
|
351 | $24,798 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
654 | $23,145 | |
| 7 | RNAC |
Cartesian Therapeutics, Inc.
|
2,029 | $21,142 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
382 | $20,834 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,424 | 52 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $40,177 | 52 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $30,874 | 40 | Shares | Sole | 2026-05-12 | |
| 2025-09-30 | $25,864 | 46 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,150 | 46 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||